Results 81 to 90 of about 4,735 (197)

Scanning electron micrographs of dutasteride loaded PLGA microspheres.

, 2014
Scanning electron micrographs of dutasteride loaded PLGA microspheres.
Yanfang Yang (408813), ZhiPing Li (5661709), Xiangyang Xie (220273), Ying Li (38224), Qiang Chi (679430), Yang Yang (45629), Hui Zhang (7197)   +6 more
core   +1 more source

The effect of dutasteride on storage symptoms in men with lower urinary tract symptoms: a REDUCE trial analysis

The Aging Male
Background Dutasteride is used to treat voiding symptoms; its impact on storage symptoms is unclear.Methods We reviewed 8122 men in the placebo and dutasteride arms from the REDUCE trial.
Alexander Hernandez-Tirado, Renning Zheng, Eman Dadashian, Farnoosh Nik-Ahd, Daniel Moreira, Stephen J. Freedland   +5 more
doaj   +1 more source

Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review [PDF]

, 2017
The 5-α-reductase inhibitors finasteride and dutasteride are frequently used in the treatment of androgenetic alopecia and benign prostatichyperplasia. These drugs are effective at reducing levels of dihydrotestosterone, the primary androgen responsible ...
Gamret, A Caresse, Darwin, Evan, Gaudi, Sudeep, Fertig, Raymond M   +3 more
core   +1 more source

Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl- β-cyclodextrin nanostructures

International Journal of Nanomedicine, 2013
Min-Soo KimDepartment of Pharmaceutical Engineering, Inje University, Gimhae, Gyeongnam, Republic of KoreaAbstract: The objectives of this study were to develop a novel solid dutasteride formulation with improved physicochemical properties and oral ...
Kim MS
doaj  

PERBEDAAN KADAR PSA DAN TGF-β1 TERHADAP PEMBERIAN KOMBINASI INHIBITOR 5α-REDUKTASE (DUTASTERIDE) DAN ANTI ESTROGEN (TAMOXIFEN) PADA PASIEN BPH LUTS

Jurnal Urologi Indonesia, 2016
Objective: To compare the PSA and TGF-β1 plasma level before and after administration of a 5α-reductase inhibitor (dutasteride) and an anti estrogen (tamoxifen) in nonobstructive patients with BPH.
Rachmat Budi Prasetyo, Soetojo Soetojo, Doddy M Soebadi   +2 more
doaj   +1 more source

PERBEDAAN IPSS, Q MAX, DAN VOLUME PROSTAT PADA PEMBERIAN KOMBINASI INHIBITOR 5α-REDUKTASE (DUTASTERIDE) DAN ANTI ESTROGEN (TAMOXIFEN) PADA PASIEN BPH YANG MENGALAMI LUTS TANPA KOMPLIKASI

Jurnal Urologi Indonesia, 2016
Objective: To compare the IPSS, Q max, and volume of the prostate pre and post treatment of 5α-reductase inhibitor and tamoxyfen in patients with BPH. Material and Methods: We collected 40 patients who had been diagnosed as BPH without urine retention ...
Kurnia Penta Seputra, Soetojo Soetojo, Doddy M Soebadi   +2 more
doaj   +1 more source

Role of dutasteride (5-alpha-reductase inhibitor) in patients undergoing transurethral resection of prostrate [PDF]

, 2018
Background: Bladder outflow obstruction due to benign prostate hyperplasia is the commonest urological condition affecting men over 50 years of age. Medical therapy is usually the first line management of BPH.
Shah, Momin, Koul, Shafeen Majid, Shah, Imtiaz, Khurshid, Omer, Koul, Shehwar Majid   +4 more
core   +1 more source

Particle size distribution of dutasteride loaded PLGA microspheres.

, 2014
Particle size distribution of dutasteride loaded PLGA microspheres.
Yanfang Yang (408813), ZhiPing Li (5661709), Xiangyang Xie (220273), Ying Li (38224), Qiang Chi (679430), Yang Yang (45629), Hui Zhang (7197)   +6 more
core   +1 more source

Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia

, 2004
Objectives To examine the rate of prostate cancer detection in three large randomized placebo-controlled benign prostatic hyperplasia trials of dutasteride. Dutasteride, which lowers serum dihydrotestosterone more than 93% by inhibiting type 1 and type 2
Schulman, Claude, Slawin, Kevin Mark, Andriole, Gerald, Roehrborn, Claus, Somerville, Matthew, Rittmaster, Roger   +5 more
core   +1 more source

Comparative Effect of Finasteride and Dutasteride on Chromogranin A Levels

, 2010
The aim of this study was to verify and to compare in benign prostatic hyperplasia (BPH) patients, the effect of finasteride versus dutasteride therapy on chromogranin A (CgA) serum levels, as a marker of neuroendocrine (NE) differentiation. Patients and
A. Gentilucci, A. Alfarone, G. Nesi, SCIARRA, Alessandro, GENTILE, Vincenzo, S. Cattarino, SALCICCIA, STEFANO   +6 more
core